感染SARS-CoV-2后患者肠道微生物群的变化:我们知道什么?
Isabel de Souza Andrade Arruda1, Caio da Silva Cavalcante1, Rebeca Siqueira Rubens1
1Laboratório de Microbiologia e Imunologia Clínica (LabMIC), Departamento de Farmácia, Faculdade de Ciências da Saúde, Universidade de Brasília (UnB), Brasília 70910-900, Brazil.
长期COVID与显著的肠道微生物群变化有关,包括减少有益细菌和增加病原体. 像益生菌这样的治疗可以帮助恢复肠道健康并缓解持续的胃肠道症状.
科学领域:
- 微生物学 微生物学
- 胃肠病学 胃肠病学
- 传染性疾病 传染性疾病
背景情况:
- COVID-19可能导致长期的胃肠道问题,称为长期COVID.
- 在COVID-19后的患者中经常观察到肠道微生物群的改变.
- 肠肺和脑肠轴与长期COVID病理生理学有关.
研究的目的:
- 为了研究SARS-CoV-2感染对肠道微生物组成的影响.
- 探索肠道微生物群在长期COVID预后和症状中的作用.
- 在长期COVID中审查肠道失生症的潜在治疗策略.
主要方法:
- 在COVID-19后的患者中分析肠道微生物群组成.
- 关于COVID-19中肠肺和脑肠轴的现有文献的审查.
- 检查肠道失生症的治疗选择.
主要成果:
- SARS-CoV-2 感染会破坏肠道平衡,减少有益细菌和增加病原体.
- 肠道微生物群的组成可能会影响患者的预后.
- 改变的肠道微生物群与长期COVID中的胃肠道症状,焦虑和抑郁有关.
结论:
- 肠道失调是长期COVID症状的一个重要因素.
- 针对肠道微生物群的治疗干预措施,如益生菌,益生菌和FMT,显示出希望.
- 恢复肠道微生物群的多样性和功能可能会改善长期COVID的结果.
更多相关视频
07:15An In Vitro Batch-culture Model to Estimate the Effects of Interventional Regimens on Human Fecal Microbiota
Published on: July 31, 2019
08:33Quantitative Polymerase Chain Reaction-based Analyses of Murine Intestinal Microbiota After Oral Antibiotic Treatment
Published on: November 17, 2018
相关概念视频
Bacterial Flora of the Large Intestine
The normal gut flora of the colon plays a critical role in generating essential vitamins such as vitamins K, B5, and B7.
Anatomy of the Intestines
Small Intestines
The small intestine is an ~7 meter-long tube with an inner diameter of just 2.5 cm. Since most nutrients are absorbed here, the inner lining of the...
What is Monogastric Digestion?
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Irritable Bowel Syndrome I: Introduction
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents
